News on Urology continually updated from thousands of sources around the net.
Trending on the Topix Network
While the number of men in the United States diagnosed with low testosterone has increased considerably over the last decade, a team of experts, led by Dr. Darius A. Paduch from NewYork-Presbyterian/Weill Cornell Medical Center, has found that relying on a blood test alone is an insufficient method of diagnosing the condition.
Have you been thinking about getting a vasectomy? If so, get in on "The 3 Point Shot Special."
Discussion of prostate-specific antigen screening should focus on current guidelines and emphasize shared decision making, according to an article published Feb. 11 in the Urology Times .
When it comes to prostate cancer, aggressive surgery saves lives and leads to a better quality of life, according to a new study that could inflame the debate over how best to treat the disease -- and in some cases, whether to treat it at all.
WEDNESDAY March 5, 2014, 2014 -- Surgery may trump a "watch-and-wait" approach when it comes to treating prostate cancer, especially in younger patients, according to a new study.
Hunterdon Healthcare is pleased to announce that the urology practice of Allen Kern, M.D. is now part of Hunterdon Healthcare Practices, the physician offices operated by Hunterdon Healthcare.
An observational study from UCLA 's Jonsson Comprehensive Cancer Center has found that prostate cancer patients who undergo robotic-assisted prostate surgery have fewer instances of cancer cells at the edge of their surgical specimen and less need for additional cancer treatments like hormone or radiation therapy than patients who have traditional ... (more)
Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.
Higher urinary levels of bisphenol A are linked to early-onset prostate cancer, according to a PLoS ONE study.
HS-410 is an investigational biologic designed to activate a T-cell mediated pan-antigen immune response for the treatment of bladder cancer.
Dear Dr. Roach : I had my prostate removed for prostate cancer in 2009 at age 70. I waited until now to start taking testosterone to feel better because I was feeling very listless with no sex drive.
The National Association For Continence presented Alan J. Wein, MD, FACS, PhD with its Rodney Appell Continence Care Champion award at the Society of Urodynamics, Female Pelvic Medicine, & Urogenital Reconstruction's 2014 Annual Meeting in Orlando, FL on February 28, 2014.
Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.
Dendreon Corporation today announced that it plans to make PROVENGE A available in Europe, beginning with Germany and the United Kingdom.